Cadre is a defensive, moat-protected public safety and nuclear safety compounder whose near-term earnings noise masks record backlog visibility and meaningful five-year upside.
Cadre Holdings Inc (CDRE) is a premier global developer, manufacturer, and distributor of highly engineered safety and survivability equipment designed for first responders, law enforcement officers, military personnel, and the civil nuclear sector.[1, 2] Operating through a robust dual-segment business model consisting of Product Manufacturing and Equipment Distribution, the company generates approximately 85% of its consolidated revenues from its proprietary, highly engineered product lines, while the specialized distribution channel contributes the remaining 15%.[2] The company maintains a diversified international manufacturing and sales footprint, selling its mission-critical products in over 100 countries.[1, 3] Domestic sales represent the core of the business, supplemented by growing operations in Canada, Mexico, and Europe.[4, 5, 6]
The company's core product portfolio is organized into four defensive, mission-critical categories: advanced body armor, high-retention duty gear, explosive ordnance disposal (EOD) systems, and specialized nuclear safety products.[3] Cadre's primary customer base includes municipal, state, and federal law enforcement agencies, the U.S. Department of Energy (DOE), the National Nuclear Security Administration (NNSA), commercial nuclear operators, and foreign ministries of defense.[1, 7, 8, 9]
| Operational Dimension | Summary of Cadre's Core Attributes |
|---|---|
| Primary Customers | Municipal, state, and federal law enforcement; US Department of Energy (DOE); NNSA; commercial nuclear power operators.[1, 7, 8, 9] |
| Key End Markets | First responder public safety, domestic and international defense, and the multi-decade nuclear waste cleanup and energy lifecycle.[2, 3, 8] |
| Value Proposition | Life-saving reliability (over 2,277 saved lives), strict regulatory certifications (NIJ standards, NNSA qualifications), and proprietary IP.[2, 3, 8, 10] |
| Revenue Model | Over 80% recurring or highly visible demand tied to mandatory government refresh cycles and multi-year defense backlogs.[3, 10, 11] |
First responders and federal agencies choose Cadre’s products over low-cost alternatives because performance is a non-discretionary, life-or-death variable.[1, 10] Ballistic panels, high-retention holsters, and chemical light solutions must perform flawlessly in hazardous or hostile environments.[1, 10] This absolute trust is supported by more than 50 years of brand equity, rigorous regulatory compliance certifications, and intense training familiarity, which collectively create exceptionally high customer retention and pricing power.[3, 4, 10]
Cadre’s strategic success is driven by its focus on niche, high-barrier product categories protected by extensive intellectual property. In the armor and duty gear categories, the company sells advanced soft and hard ballistic panels, plate carriers, and tactical vests via legendary brands such as Safariland, GH Armor, and Protech, alongside Bianchi Leather holsters and duty accessories.[7, 12] The newly commercialized SX HP ballistic panels represent a significant technological breakthrough, providing lighter, thinner, and more comfortable protection that meets the most demanding ballistic testing protocols in the industry.[10]
In the explosive ordnance disposal (EOD) category, Cadre’s Med-Eng and ICOR Technology subsidiaries supply military-grade bomb suits, specialized remote tactical robotic vehicles, and highly engineered blast-attenuation seats designed to mitigate vertical energy transfers from under-vehicle improvised explosive devices (IEDs).[5, 7, 13] The nuclear safety portfolio, expanded through Alpha Safety and Carr's Engineering Division, consists of ventilation containment systems, engineered containers co-developed with the NNSA for storing plutonium oxides, radiometric instrumentation, and specialized remote robotic arms used in complex decommissioning projects.[8, 14] The company-owned distribution channel, operating under retail platforms such as Atlantic Tactical and Lawmen's, provides municipal agencies with an integrated, single-source procurement platform for uniforms, weapons, and tactical gear, allowing Cadre to capture additional margin across the public safety value chain.[3, 7]
The competitive advantage of Cadre is supported by a multi-layered economic moat. High customer switching costs serve as a primary barrier to entry.[3] First responders undergo rigorous, department-mandated training on specific duty gear systems, such as Safariland’s Automatic Locking System (ALS) and Self Locking System (SLS) duty holsters.[4, 15] Transitioning to an alternative holster manufacturer would require department-wide retraining programs and certified qualification trials, making police chiefs highly reluctant to switch brands.[4] In the nuclear safety segment, containment equipment and engineered containers are built to fit the precise, custom physical footprints of federal facilities, making the cost of substitution operationally prohibitive and introducing severe safety risks.[8]
Furthermore, Cadre's product lines are heavily protected by stringent regulatory and certification requirements.[3] Ballistic panels must undergo multi-year testing to secure National Institute of Justice (NIJ) certifications, while nuclear containment containers require rigorous design approvals from the DOE and NNSA.[3, 8, 9] These regulatory approvals represent a high barrier to entry for lower-cost foreign competitors. Finally, Cadre enjoys a scale and distribution advantage through its integrated supply chain.[2, 3] As the largest consolidated operator in a fragmented industry, Cadre leverages its company-owned distribution platform to self-distribute its manufactured products, optimizing logistics, reducing freight costs, and securing direct, multi-year relationships with state and local purchasing agents.[2, 3]
The serviceable addressable market (SAM) for Cadre's core product groups—including duty gear, explosive ordnance disposal, and body armor—is estimated at approximately $2.0 billion.[3, 8] The strategic acquisitions of Alpha Safety and Carr's Engineering Division have expanded the addressable boundary.[5, 14] The domestic nuclear safety and products market features a highly visible TAM of $3.0 billion to $6.0 billion, which expands Cadre’s combined addressable opportunity set to an estimated $5.0 billion to $8.0 billion.[8, 9]
This market is supported by long-term, non-discretionary federal funding tailwinds.[2, 16] These include the NNSA's legislative mandate to ramp domestic nuclear pit production capacities to a minimum of 80 pits annually by 2030, alongside the Department of Energy’s environmental liabilities spanning multiple decades across key sites requiring continuous remediation.[9, 16]
The global safety equipment market is highly fragmented, with Cadre uniquely positioned as the premium consolidated player. In the ballistic armor vertical, Cadre competes against Point Blank Enterprises, Armor Express, and various regional manufacturers, while its duty gear division faces competition from brands like Blackhawk, Gould & Goodrich, and regional holster makers.[17, 18] Despite this competitive landscape, Cadre has demonstrated an ability to capture market share.[10] This was highlighted by the Federal Bureau of Investigation's (FBI) recent selection of Safariland's SX HP ballistic panel for its five-year, $61.0 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract, in which Safariland's proprietary technology was chosen over 11 competing industry submissions after demanding field evaluation.[10]
Rather than engaging in pricing matches in the commercial consumer space, Cadre focuses on institutional accounts and B2B contracts where its technical specifications command premium pricing.[3, 10] This strategic focus is enhanced by its systematic acquisition playbook.[3] By buying niche market leaders—such as the recent additions of TYR Tactical for $185.2 million and Alien Gear Holsters for $10.3 million—Cadre successfully eliminates competitive threats, absorbs valuable intellectual property, and drives scale-related purchasing synergies.[13, 19]
Cadre Holdings reported its financial results for the first quarter of fiscal 2026, ended March 31, 2026, on May 11, 2026.[13, 20] The company’s top line demonstrated robust growth driven by strategic acquisitions, while GAAP profitability was compressed due to integration-related expenses, non-cash amortization, and elevated interest costs.[13, 21]
Q1 2026 Revenue Performance:
Expected: $156.66M [21]
Actual: $155.40M [21] (Miss of 0.8%)
Q1 2026 Diluted EPS Performance:
Expected: $0.10 [21]
Actual: $0.05 [21] (Miss of 50.0%)
Net sales for the quarter reached $155.4 million, representing a 19.5% year-over-year increase compared to the $130.1 million reported in the first quarter of 2025, primarily driven by the inclusion of TYR Tactical.[13, 19] This result fell slightly short of consensus analyst expectations of $156.66 million by approximately 0.8%.[21]
GAAP diluted earnings per share (EPS) came in at $0.05, representing a 50.0% miss relative to the analyst consensus estimate of $0.10.[21] Net income contracted sharply to $2.0 million from the $9.2 million reported in Q1 2025, primarily as a result of a $10.1 million rise in total operating expenses, which reached $52.7 million due to increased compensation, transaction-related advisory costs, and related party expenses.[13]
Consolidated gross profit margin contracted to 38.7% from 43.1% in the prior year's first quarter, driven by inventory step-up amortization from acquisitions and an unfavorable near-term product mix.[13] Adjusted EBITDA rose slightly to $21.1 million from $20.5 million, while Adjusted EBITDA margin compressed to 13.6% from 15.8% in Q1 2025.[13]
Within the Product segment, gross margin fell to 39.9% from 44.4% in the prior-year period, primarily due to step-up amortization from the TYR Tactical acquisition.[13, 19] The Distribution segment recorded a gross margin of 19.7% compared to 21.6% in the first quarter of 2025, reflecting lower demand for discretionary hard goods.[13]
On the balance sheet, cash and cash equivalents decreased by $81.6 million during the quarter to $41.3 million as of March 31, 2026, reflecting the substantial cash deployed for the TYR Tactical transaction.[13] Total debt rose by $58.5 million to $365.8 million, which increased the company's net debt position to $324.6 million.[13]
Management fully reaffirmed its previously announced full-year 2026 guidance, reflecting confidence in back-half margin normalization and backlog delivery.[13, 21] The company continues to target record performance:
* Net Sales: $736 million to $758 million.[13, 21]
* Adjusted EBITDA: $136 million to $141 million.[13, 21]
* Capital Expenditures: Expected in the range of $10 million to $14 million.[13]
During the conference call, CFO Blaine Browers highlighted that the Q1 margin profile was consistent with internal forecasts, pointing to the temporary mix headwind in armor and nuclear driven by the specific composition of the Q1 backlog.[22] He noted that margins are expected to improve sequentially as the company leverages increasing revenues and rolls off purchase price accounting adjustments.[22]
President Brad Williams highlighted minor demand softening for discretionary items in the company-owned distribution segment and noted localized city budget headwinds.[22] However, he emphasized that nuclear and defense indicators remain robust, with the DOE's 2027 budget up 10% overall.[22]
He explained that while non-NNSA nuclear funding was down 11%, this shift is constructive as it redirects demand toward defense-related nuclear containment, air filtration, and robotic systems—verticals where Cadre's Alpha Safety and Carr's Engineering brands command superior pricing.[7, 8, 14, 22] Additionally, management addressed the near-term nuclear drag from the executive order reducing plutonium downblending, noting that it has created timing-related volatility for Alpha Safety, which will be mitigated by commercial nuclear projects over the medium term.[11]
The stock price experienced a 4.92% drop in after-hours trading immediately following the earnings release, closing at $28.38 on May 12, 2026, as investors reacted to the GAAP EPS shortfall.[21] Year-to-date, the stock has experienced pressure, down roughly 27.0%.[21]
However, Wall Street analysts have maintained their constructive ratings, treating the GAAP earnings compression as a temporary transaction-driven event rather than a structural issue.[23] The consensus recommendation remains a "Strong Buy," with five analysts providing an average 1-year price target of $46.80 (representing roughly 65.6% upside from the current share price of $28.25), with individual targets spanning from $40.00 to $62.00.[24, 25]
| Metric | Cadre Holdings (CDRE) | direct Peer Average | RTX Corp (RTX) | Honeywell Aerospace |
|---|---|---|---|---|
| Trailing P/E Multiple | 32.8x [24] | 37.3x [24] | 34.4x [24] | 31.6x [24] |
| P/E vs. Industry (Aero/Def) | Good Value (32.8x vs. 40.3x Industry Average) [24] | Standard Premium | In-Line | In-Line |
| EV / Forward EBITDA | 11.2x (Using FY26 Midpoint) [21, 26] | 14.5x | 16.2x | 15.0x |
| PEG Ratio | 1.2x [24] | 1.5x | 2.1x | — |
The most important underlying financial driver for Cadre is its order backlog, which surged to an all-time high of $355.0 million (including $108.0 million of organic backlog growth from Q4 to Q1).[13, 21] This backlog provides strong visibility for future revenues, particularly through the $86.4 million GDELS blast-attenuation seat contract which is expected to ramp up through 2026 and 2027.[13]
Additionally, the company’s underlying cash-flow engine remains strong.[27] Cadre operates an asset-light business model requiring minimal capital expenditures, historically averaging just 1.1% of sales (generating $63.7 million in operating cash flow in FY2025).[27] The primary financial metric driving long-term valuation is its historical 5-year sales CAGR of 8.57% (calculated from $404.64 million in 2020 to $610.31 million in 2025), which has supported steady, non-dilutive compounding.[28]
Cadre’s roll-up strategy is highly dependent on continuous M&A execution.[3] Integrating large businesses such as TYR Tactical (acquired for $185.2 million) and Carr's Engineering Division presents significant integration risks, including potential supply chain friction and accounting systems consolidation.[14, 19] Delays in achieving planned operational synergies can result in prolonged gross margin dilution, as seen in the Q1 2026 results where inventory step-up amortization heavily impacted GAAP profits.[13] Competitive risks are centered in the municipal and federal bidding processes, where Cadre’s soft armor and tactical holster divisions must continuously defend their market share against Point Blank Enterprises and other specialized manufacturers during multi-year purchasing cycles.[10, 18]
In the first responder end market, Cadre is exposed to state and local fiscal health.[22] Localized city budget deficits can lead to deferred procurement of officer uniforms, duty gear, and discretionary equipment, which directly impacts the company’s Distribution segment.[22] In the nuclear safety division, the company is highly dependent on federal appropriations.[22] Shifts in federal cleanup timelines, project delays by the Department of Energy, or policy shifts—such as the recent executive order reducing plutonium downblending—can create backlog volatility and near-term margin pressure on subsidiaries like Alpha Safety.[11]
Because Cadre’s products are designed for life-saving applications, any manufacturing defect or ballistic failure represents a severe risk.[1] A product recall or decertification by the National Institute of Justice (NIJ) would damage brand equity, invite catastrophic product liability claims, and disqualify the company from municipal bidding registries.[3, 10]
On the capital allocation front, the company's net debt has increased to $324.6 million following the TYR Tactical acquisition, pushing net leverage to 2.9x net debt-to-EBITDA.[2, 13] This elevated leverage, coupled with rising interest expenses (which doubled to $4.27 million in Q1 2026), could limit Cadre's financial flexibility for future acquisitions or cash dividend growth.[13, 29]
Cadre's global footprint introduces foreign exchange transaction risks, particularly with the Mexican Peso (MXN) and British Pound (GBP), which can create currency translation headwinds on consolidated cost of goods sold.[4, 5, 6] Additionally, inflation in raw materials (including high-performance fibers, plastics, and specialized steel alloys) can pressure gross margins if the company faces temporary delays in passing these costs down to institutional clients under fixed-price contracts.[13]
| Risk Dimension | What Could Go Wrong | Early Warning Signs | Long-Term Thesis Damage |
|---|---|---|---|
| Municipal Funding | Local city deficits force a deferred replacement of safety equipment.[22] | Sequential sales declines and rising inventory in the Distribution segment.[13, 22] | Structural municipal budget cuts that break the 5-year armor refresh cycle.[3] |
| Product Liability | A key ballistic panel or holster line fails to meet field expectations.[1] | An uptick in customer warranty claims or quality control reviews.[3] | A major NIJ decertification or high-profile legal liability claim.[3, 10] |
| M&A Execution | Integration delays or failure to achieve expected cost synergies.[3] | Persistent step-up amortization and elevated SG&A as a percent of sales.[13] | Persistent return on invested capital (ROIC) contraction and asset write-downs.[3] |
| Federal Policy | Shifts in nuclear cleanup budgets or downblending priorities.[11] | Flatlining or contraction in the nuclear safety segment's backlog.[13] | The cancellation of core NNSA pit production or long-term waste remediation programs.[9] |
To evaluate Cadre's potential valuation and share price trajectory over a five-year horizon (projected to FY 2031, ending December 31, 2031), three operational scenarios have been developed based on fundamental inputs, historical growth rates, and structural margin targets.
The models assume a baseline diluted share count of 42.80 million, which is expected to experience moderate dilution to 44.50 million in the Base and High cases due to equity incentives, while remaining at 43.50 million in the Low Case due to restricted issuances.[26, 30] The starting share price is $28.25.[30]
Under this scenario, Cadre is assumed to successfully integrate its recent acquisitions, maintain its core public safety market share, and leverage its record orders backlog.[13, 21]
* Revenue Growth: Starts with the FY2026 guidance midpoint of $747.0 million.[21] Thereafter, revenue grows at an organic CAGR of 5.0% coupled with disciplined, non-dilutive acquisitions adding $25.0 million in annual sales, leading to a total five-year revenue CAGR of 7.0%.
$\text{FY2031 Revenue} = \$747.0\text{M} \times (1.07)^5 = \$1,048.0\text{M}$
* Adjusted EBITDA Margin: Gradually expands from 18.5% to 21.0% by FY2031 as the high-margin military blast attenuation seat contracts ramp up and acquisition step-up amortization rolls off.[13, 22]
$\text{FY2031 Adjusted EBITDA} = \$1,048.0\text{M} \times 21.0\% = \$220.1\text{M}$
* Balance Sheet / Debt: The company utilizes its strong free cash flow to pay down debt, reducing net debt from $324.6 million to $150.0 million.[13]
* Valuation Multiple: An exit EV/EBITDA multiple of 13.0x is applied, slightly below its historical trading premium to reflect a mature corporate profile.
$\text{FY2031 Enterprise Value (EV)} = \$220.1\text{M} \times 13.0 = \$2,861.3\text{M}$ $\text{FY2031 Implied Equity Value} = \$2,861.3\text{M} - \$150.0\text{M (Net Debt)} = \$2,711.3\text{M}$ $\text{Projected Share Price} = \frac{\$2,711.3\text{M}}{44.50\text{M shares}} = \$60.93\text{ USD}$
This scenario models a highly successful execution of the long-term strategic vision, where Cadre scales its nuclear division, benefits from robust defense spending, and hits its aspiration of mid-20s% margins.[3, 8, 22]
* Revenue Growth: Revenue grows from the $747.0 million base at a total CAGR of 10.0% (organic and inorganic combined), supported by large-scale domestic nuclear containment remediation programs.[8]
$\text{FY2031 Revenue} = \$747.0\text{M} \times (1.10)^5 = \$1,203.0\text{M}$
* Adjusted EBITDA Margin: Reaches 24.0% by FY2031, satisfying management's long-term operating goal through superior pricing power and structural mix shift toward high-margin proprietary products.[3]
$\text{FY2031 Adjusted EBITDA} = \$1,203.0\text{M} \times 24.0\% = \$288.7\text{M}$
* Balance Sheet / Debt: Net debt is aggressively paid down to $50.0 million.
* Valuation Multiple: An exit EV/EBITDA multiple of 15.0x is justified by superior profitability, high returns on capital, and unique defense-tech alignment.
$\text{FY2031 EV} = \$288.7\text{M} \times 15.0 = \$4,330.5\text{M}$ $\text{FY2031 Implied Equity Value} = \$4,330.5\text{M} - \$50.0\text{M} = \$4,280.5\text{M}$ $\text{Projected Share Price} = \frac{\$4,280.5\text{M}}{45.00\text{M shares}} = \$95.12\text{ USD}$
This scenario assumes prolonged municipal budget freezes, integration failure of the TYR Tactical acquisition, and persistent federal budget delays in nuclear containment projects.[11, 22]
* Revenue Growth: Revenue grows at a sluggish CAGR of 3.0% from the $747.0 million base, representing flat organic volume growth and minimal M&A contributions.
$\text{FY2031 Revenue} = \$747.0\text{M} \times (1.03)^5 = \$866.0\text{M}$
* Adjusted EBITDA Margin: Contracts to 15.0% due to negative product mix, promotional pricing in consumer holster channels, and operational inefficiencies.
$\text{FY2031 Adjusted EBITDA} = \$866.0\text{M} \times 15.0\% = \$129.9\text{M}$
* Balance Sheet / Debt: Weak cash conversion prevents debt reduction, leaving net debt elevated at $250.0 million.
* Valuation Multiple: Multiple contracts to 10.0x EV/EBITDA as the market discounts the company's roll-up strategy and elevated leverage.
$\text{FY2031 EV} = \$129.9\text{M} \times 10.0 = \$1,299.0\text{M}$ $\text{FY2031 Implied Equity Value} = \$1,299.0\text{M} - \$250.0\text{M} = \$1,049.0\text{M}$ $\text{Projected Share Price} = \frac{\$1,049.0\text{M}}{43.50\text{M shares}} = \$24.11\text{ USD}$
| Scenario | Year 0 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 (FY2031) |
|---|---|---|---|---|---|---|
| High Case | 28.25 | 36.50 | 47.00 | 60.50 | 77.00 | 95.12 |
| Base Case | 28.25 | 33.00 | 38.50 | 45.00 | 52.50 | 60.93 |
| Low Case | 28.25 | 27.00 | 26.00 | 25.00 | 24.50 | 24.11 |
Applying probability weights of 55% to the Base Case, 25% to the High Case, and 20% to the Low Case yields an expected value share price target of $62.11 USD five years out:
$\text{Expected Price} = (\$60.93 \times 0.55) + (\$95.12 \times 0.25) + (\$24.11 \times 0.20) = \$33.51 + \$23.78 + \$4.82 = \$62.11\text{ USD}$
| Scenario | Year 5 Revenue ($M) | Year 5 EBITDA % | Exit EV/EBITDA Multiple | Current Price (USD) | Implied Year 5 Price (USD) | 5-Year Total Return | Annualized Return | Probability |
|---|---|---|---|---|---|---|---|---|
| High Case | 1,203.0 | 24.0% | 15.0x | 28.25 | 95.12 | 236.7% | 27.5% | 25.0% |
| Base Case | 1,048.0 | 21.0% | 13.0x | 28.25 | 60.93 | 115.7% | 16.6% | 55.0% |
| Low Case | 866.0 | 15.0% | 10.0x | 28.25 | 24.11 | -14.7% | -3.1% | 20.0% |
| Weighted Expected | 1,042.6 | 20.0% | 12.6x | 28.25 | 62.11 | 119.9% | 17.1% | 100.0% |
ASYMMETRIC RETURN PROFILE
Under no circumstances does this qualitative scorecard constitute financial advice or investment recommendations. All ratings are structural assessments of the business model for professional evaluation.
| Dimension | Score (1-10) | Narrative Analysis of Score |
|---|---|---|
| Management Alignment | 8 / 10 | Warren Kanders holds ~38% of outstanding common stock and ~40% of the voting power, creating strong alignment.[31] Recent executive performance stock options feature highly ambitious targets ($60.00 and $80.00 per share), though recent insider selling introduces minor near-term technical overhang.[23, 26] |
| Revenue Quality | 9 / 10 | Over 80% of sales are tied to regulatory replacement cycles, backed by long-term government contracts and non-discretionary municipal budgets, resulting in high predictability.[3, 10] |
| Market Position | 9 / 10 | Unrivaled brand trust and market leadership in law enforcement duty gear and EOD systems.[3, 4] The FBI's selection of the SX HP panel over 11 competitors validates its leading position.[10] |
| Growth Outlook | 8 / 10 | Driven by robust defense backlogs, expanding nuclear SAM ($5-8B), and systematic roll-up acquisitions.[3, 8, 11] |
| Financial Health | 6 / 10 | High cash flow generation is balanced by an elevated leverage of 2.9x net debt-to-EBITDA following the TYR Tactical transaction.[2, 13] Interest expenses have doubled to $4.27M in Q1 2026.[13] |
| Business Viability | 9 / 10 | Highly durable business model.[3] Public safety equipment and nuclear lifecycle remediation are basic civil necessities with virtually no risk of technological obsolescence.[2, 8] |
| Capital Allocation | 7 / 10 | Disciplined M&A playbook acquiring leaders at 5x to 11x EBITDA.[3] Dividend raised 5.3% in early 2026, though leverage reduces near-term capacity for large capital deployments.[13, 29] |
| Analyst Sentiment | 9 / 10 | Consensus "Strong Buy" rating with price targets indicating significant upside potential from the current price.[24, 25] |
| Profitability | 8 / 10 | Historical gross profit margin of 42.5%.[29] Near-term margin pressure is transactional and expected to normalize.[13, 22] |
| Track Record | 8 / 10 | 153% total shareholder return since late 2021 IPO, driven by operational execution and successful acquisition integration.[3, 32] |
$\text{Blended Score} = \frac{8+9+9+8+6+9+7+9+8+8}{10} = 8.1 / 10$
DEFENSIVE MARKET LEADER
Under no circumstances does this analysis provide investment advice or recommendations. This report is structured strictly as an institutional research resource.
The core investment thesis for Cadre Holdings Inc centers on a high-quality, defensively insulated public safety compounder that has been temporarily mispriced due to near-term GAAP earnings noise.[3, 21] The market has heavily penalized the stock for its Q1 2026 GAAP earnings shortfall, overlooking the underlying operational momentum.[21]
While GAAP profitability was compressed by step-up inventory amortization, acquisition transaction costs, and short-term segment mix shifts, Cadre's forward-looking demand indicators are stronger than ever.[13, 21, 22] The company’s orders backlog has surged to an all-time record of $355.0 million.[21] This substantial backlog, combined with the integration of TYR Tactical and the multi-year $86.4 million GDELS blast-attenuation seat contract, provides highly visible and predictable top-line revenue through the end of the decade.[13, 21]
Key operational catalysts over the next 12 to 24 months include:
1. Deleveraging of the Balance Sheet: Directing robust free cash flow toward debt paydown, bringing leverage back to its historical comfort zone of under 2.0x net debt-to-EBITDA.[27]
2. Margin Recovery: The roll-off of transaction-related inventory step-up amortization and a positive mix shift as high-margin military blast seats and nuclear containment orders ramp into full production.[13, 22]
3. Accretive Integration: Realizing immediate earnings and cost-synergy accretion from the TYR Tactical and Alien Gear Holsters integrations.[13, 33]
At its current share price of $28.25, Cadre trades at a massive discount of more than 40% relative to its conservative, probability-weighted five-year target value of $62.11.[24] For investors with a medium-to-long-term horizon, the temporary fundamental noise represents an attractive operational entry point into a highly defensive, moat-protected compounder.
STRUCTURALLY UNDERVALUED COMPOUNDER
Cadre’s technical posture remains bearish in the near term, with the current share price of $28.25 trading below both its 50-day moving average of $29.51 and its 200-day moving average of $29.99.[34] The stock is navigating a consolidation pattern after testing its 52-week low of $25.73 post-earnings, creating a localized technical support floor.[34, 35] Short-term trading sentiment is balanced between headwind pressures from recent insider selling disclosures and positive long-term momentum generated by substantial, performance-linked executive option grants with ambitious $60.00 and $80.00 targets.[23] Consequently, expect the stock to undergo constructive sideways consolidation before fundamental backlog execution drives a technical reversal toward the 200-day moving average.
SUPPORT FLOOR CONSOLIDATION
View Cadre Holdings, Inc. (CDRE) stock page
Loading the interactive version of this report…